Related Experiment Videos
[Blood lipids as a factor of hereditary susceptibility to ischemic heart disease]
Kardiologiia
|June 1, 1989
Insights
Genetic factors significantly influence coronary heart disease (CHD) and lipid metabolism in myocardial infarction (MI) patient families. Close relatives often exhibit monogenic hyperlipoproteinemias, indicating a strong hereditary component.
Area of Science:
- Cardiovascular Medicine
- Human Genetics
- Metabolic Disorders
Context:
- Myocardial infarction (MI) is a leading cause of mortality globally.
- Family history is a known risk factor for coronary heart disease (CHD).
- Understanding the genetic basis of CHD is crucial for risk stratification and prevention.
Purpose:
- To investigate the familial aggregation of CHD and associated lipid metabolism shifts in patients with myocardial infarction.
- To identify the role of genetic factors in the development of atherogenic lipid profiles.
- To determine the prevalence of specific genetic lipid disorders in relatives of MI patients.
Summary:
- A study of 166 families of myocardial infarction patients revealed significant familial aggregation of coronary heart disease.
- Atherogenic shifts in lipid turnover parameters were observed, strongly influenced by genetic factors.
- Close relatives of MI patients showed a high prevalence of monogenic forms of hyperlipoproteinemias.
Impact:
- Highlights the substantial genetic contribution to coronary heart disease and dyslipidemia.
- Suggests genetic screening for hyperlipoproteinemias in relatives of MI patients may be beneficial.
- Informs personalized risk assessment and potential therapeutic strategies for cardiovascular disease.
Abstract:
Examination of 166 families of the patients who had sustained myocardial infarction revealed aggregation of coronary heart disease in the families and the atherogenic shifts in the parameters of lipid turnover, which were caused by significant influences of genetic factors. The close relatives of the postinfarction patients were shown to display a large proportion of monogenic forms of hyperlipoproteinemias.